Regional Strategic Sales Director - MidAtlantic

Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFR CT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFR CT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare. Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 500,000 patients worldwide. The Regional Strategic Sales Director (RSD) is a high-impact leadership role responsible for the strategic expansion, and long-term adoption of Heartflow’s portfolio.The RSD will focus on high-level C-suite engagement, CV service line optimization, and scaling Heartflow’s full suite of solutions across the region. For FY26, the immediate priority is the successful launch of PCI Navigator — Heartflow’s new pre-procedural planning solution for Percutaneous Coronary Intervention (PCI). Job Responsibilities: Strategic Account Leadership Portfolio Growth Executive Partnership: Manage deep, consultative relationships with C-suite stakeholders, key clinical champions and CV Service Line leaders to align institutional priorities with Heartflow’s offering. Portfolio Adoption: Develop regional plan for the expansion and differentiation of the Heartflow One Platform Establish Program Building Plans: In partnership with CV service line leadership, drive the CCTA program goals and deliverables. Partnering with the local territory teams, lead Quarterly Program Reviews (QPRs) to key stakeholders and decision makers at key accounts. PCI Navigator Launch Initial Clinical Adoption: In partnership with the TSM, lead the clinical introduction of PCI Navigator, identifying and activating Interventional Cardiology (IC) and key cath lab staff to establish CT-guided PCI as a new pre-procedural standard. Workflow: Partner with multi-disciplinary stakeholders (Radiology, Cardiology, and IT) to develop and integrate seamless clinical pathways. Long term Adoption: Ensure Cath Lab is set up for success for independent use of the PCI Navigator to ensure long-term account self-sufficiency. Medical Education : Drive system wide medical education programs across all appropriate stakeholders. Market Development Influence KOL Identification: Work cross functionally in partnership with Medical Affairs to cultivate regional and national Key Opinion Leaders (KOLs) to drive support for the CCTA + Heartflow pathway and lead peer-to-peer educational initiatives. Market Intelligence: Gather and communicate voice of customer input and competitive intelligence to guide future product development and market strategy. Educational Requirements Work Experience: BA/BS Degree required. 8+ years of healthcare sales experience; medical device or healthcare technology sales experience is required. Proven track record of navigating hospital executive leadership and the C-suite. Demonstrated ability to launch new categories or disruptive medical technologies. Ability to travel up to 70-80% within the assigned region. Preferred Qualifications (Nice to Haves): Cath Lab Expertise: Deep understanding of Interventional Cardiology workflows; experience with PCI, TAVR, or EVAR is highly preferred. ... (truncated, view full listing at source)